IMI is organising a series of online live sessions on IMI’s Impact, where key actors will explore the challenges and demonstrate how IMI contributed.
In this context IMI has decided to showcase IMI’s impact in specific areas, starting with three topics: diabetes, dementia and the relatively new field of data management. During these sessions, IMI will also share patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research. Furthermore, IMI hopes to engage IMI stakeholders in a broader discussion on IMI’s impact and ask them for their active participation in these live events.
The IMI event on dementia will take place on 15 June at 2:00pm CET. We are pleased that our project co-lead Gill Farrar will be presenting the AMYPAD project.
To register and find out more about each online session please click here.
We are happy to invite you to the public defence of the dissertation "The AMYPAD project: Towards the next stage in amyloid PET imaging" by Lyduine Collij to be held on Thursday, July 1st, 2021 at 09:45 CET.
Streamed via https://www.youtube.com/c/VUBeadlesOffice
Join AAIC 2021 in-person (Amsterdam, the Netherlands) or virtually. The world’s leading basic scientists, clinical researchers, early career investigators, clinicians and the care research community will share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer’s disease.
The event will take place from 26-30 July 2021.
Seven AMYPAD abstracts have been accepted (1 oral & 6 posters). More information will be shared in due time:
Information on conference registrations can be found HERE.